Here are what the editors at HealthDay consider to be the most important developments in Dermatology for June 2008. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Non-Steroidal Drugs Don't Protect Against Melanoma
THURSDAY, June 26 (HealthDay News) -- The use of non-steroidal anti-inflammatory drugs (NSAIDs) doesn't appear to be associated with a lower risk of melanoma, contrary to data supporting their chemopreventive effects for other site-specific cancers, according to research published in the July 2 issue of the Journal of the National Cancer Institute.
Abstract
Full Text (subscription or payment may be required)
Long-Pulsed Dye Laser Superior for Sun Damage
MONDAY, June 23 (HealthDay News) -- In patients with sun-damaged skin, treatment with long-pulsed dye laser rejuvenation produces better outcomes than treatment with intense pulsed light, according to a report published online June 18 in Lasers in Surgery and Medicine.
Abstract
Full Text (subscription or payment may be required)
Article Examines Use of 'Key Opinion Leaders' in Drug Sales
FRIDAY, June 20 (HealthDay News) -- Influential doctors known as "key opinion leaders" are paid generous fees to influence their peers to prescribe a company's drugs and may in fact be considered salespeople by the industry, according to an article in the June 21 issue of BMJ.
Full Text - Moynihan
Editorial - Buckwell
Editorial - Fava
Sixty-Second Hair Count Assesses Shedding
WEDNESDAY, June 18 (HealthDay News) -- Counting the number of hairs shed after combing for 60 seconds in the morning is a simple and reliable way to assess hair shedding, according to a report in the June issue of the Archives of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Amniotic Membranes Effective for Serious Skin Disease
TUESDAY, June 17 (HealthDay News) -- A patient with a rare life-threatening skin disease involving detachment of the skin over half the body recovered completely after being given intravenous immunoglobulin (IVIG) and placing amniotic membranes on the affected areas, according to a case study reported in the June issue of the Archives of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Melanoma Should Trigger Regular Eye Checks
FRIDAY, June 13 (HealthDay News) -- The incidence of melanoma is increasing more quickly than any other cancer in the United States, and patients with metastatic cutaneous melanoma should be periodically given an ophthalmic examination to screen for metastasis to the eye, lids and orbit, according to a study published in the May/June issue of the Survey of Ophthalmology.
Abstract
Full Text (subscription or payment may be required)
Drug Effective for Severe Hemangiomas in Children
WEDNESDAY, June 11 (HealthDay News) -- Propranolol is effective in treating severe capillary hemangiomas in children, relieving redness, and softening and flattening the lesions, according to an article in the June 12 issue of the New England Journal of Medicine.
Abstract
Full Text
Myeloma Drug Relieves Lupus Pathology in Mice
WEDNESDAY, June 11 (HealthDay News) -- Treating mice with lupus with bortezomib, a drug approved to treat multiple myeloma, eliminates autoreactive plasma cells, reduces glomerulonephritis and improves survival, according to study findings published online June 8 in Nature Medicine.
Abstract
Full Text (subscription or payment may be required)
No Consensus on Screening Tests for Psoriasis Patients
WEDNESDAY, June 4 (HealthDay News) -- There is no strong evidence either for or against the use of screening and monitoring of psoriasis patients treated with biologic agents, and the extent of monitoring should be decided on an individual patient basis, according to a report published in the June issue of the Journal of the American Academy of Dermatology.
Abstract
Full Text (subscription or payment may be required)
